rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

GE HealthCare Technologies Inc.

GEHC · Nasdaq

Health CareMedical DevicesAbove a falling averageAI

GEHC stood above a rising 150-day average in 16 of the last 52 weekly readings, and has been out of that trend for the last 33 weeks. It is 3.8% above that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Above a falling average
Weeks in an uptrend
out for 33
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$12.8M
Insider sales, 12 months
$0
Officials’ trades on record
19
Institutions holding
1,152 (-41)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 16 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$11.7MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

19 disclosed lines: House 7, Senate 1, executive 11; 7 people.

WhoDidAmountTraded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k20 Jul 2026filed 22 Sep 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k17 Jul 2026filed 22 Sep 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k17 Jul 2026filed 22 Sep 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$15k–$50k16 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$15k–$50k11 May 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$100k–$250k17 Apr 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k15 Apr 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k10 Apr 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k7 Apr 2026filed 1 Jul 2026
Alan Armstrong Senate: U.S. Senate eFDSenatorbought$1k–$15k27 Mar 2026filed 21 Jul 2026
Terri A. Sewell House: U.S. House ClerkAL07sold$1k–$15k25 Mar 2026filed 21 Apr 2026
Warren Davidson House: U.S. House ClerkOH08sold$1k–$15k23 Mar 2026filed 25 Mar 2026

Insiders

Buy orders, 12 months8
Sale orders, 12 months0
Buyers · sellers8 · 0
WhoDidSharesTraded
Kevin LoboDirectorbought10,000at $64.1822 May 2026filed 26 May 2026
Rodney F. HochmanDirectorbought1,618at $62.0312 May 2026filed 13 May 2026
Watkin Phoebe L. YangDirectorbought1,000at $63.018 May 2026filed 11 May 2026
H. Lawrence Culp, Jr.Directorbought80,805at $61.886 May 2026filed 7 May 2026
William J. StrombergDirectorbought1,000at $61.696 May 2026filed 7 May 2026
James SaccaroChief Financial Officerbought3,310at $60.601 May 2026filed 1 May 2026
Peter J. ArduiniPresident and CEObought4,169at $59.9330 Apr 2026filed 30 Apr 2026
Frank R. JimenezGC & Corporate Secretarybought1,750at $60.4530 Apr 2026filed 30 Apr 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders1,152-41 on the quarter
New · exited133 · 176
Reported value$24.9B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Dodge & Coxadded · filed 13 Aug 202637,864,164$2.4B+6,552,100+20.9%
BlackRock, Inc.added · filed 7 Aug 202637,467,843$2.4B+1,483,516+4.1%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 202629,724,359$1.9B+860,171+3.0%
STATE STREET CORPadded · filed 7 Aug 202620,861,566$1.3B+323,090+1.6%
VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 202620,275,526$1.3B+1,092,369+5.7%
Invesco Ltd.added · filed 14 Aug 202618,296,350$1.2B+10,558,042+136.4%
HARRIS ASSOCIATES L Preduced · filed 14 Aug 202615,329,664$981.3M-265,324−1.7%
BARROW HANLEY MEWHINNEY & STRAUSS LLCadded · filed 12 Aug 202613,455,814$861.3M+1,571,226+13.2%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 202612,871,800$820.8M+472,165+3.8%
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLCadded · filed 14 Aug 202612,250,502$784.2M+2,282,629+22.9%
31 Mar 2023 – 30 Jun 2026
90110691236Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

William K. Grogan Company insiderChief Financial Officer · last 14 Sep 20260 · 0
Adam Y. Holton Company insiderChief People Officer · last 3 Sep 20260 · 0
Catherine Estrampes Company insiderChief Commer. & Growth Officer · last 3 Sep 20260 · 0
Frank R. Jimenez Company insiderGC & Corporate Secretary · last 3 Sep 20262 · 0
George A. Newcomb Company insiderChief Accounting Officer · last 3 Sep 20260 · 1
Kevin Michael O'Neill Company insiderCEO, PDx · last 3 Sep 20260 · 1
Peter J. Arduini Company insiderPresident and CEO · last 3 Sep 20261 · 0
Philip Rackliffe Company insiderCEO, AIS · last 3 Sep 20260 · 1
Taha Kass-Hout Company insiderChief Technology Officer · last 3 Sep 20260 · 1
Jeannette Bankes Company insiderCEO, Patient Care Solutions · last 1 Sep 20260 · 0
Donald J. Trump Executive branchWhite House Office · last 20 Jul 20264 · 6
Kevin Lobo Company insiderDirector · last 22 May 20261 · 0

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202540.0%
Operating profit marginFY 2025 · to 31 Dec 202513.4%
Free cash flow marginFY 2025 · to 31 Dec 20257.3%
Return on capital employedFY 2025 · to 31 Dec 20259.9%
Cash conversionFY 2025 · to 31 Dec 202595.3%
Debt to equityFY 2025 · to 31 Dec 20251.01×
Research spendFY 2025 · to 31 Dec 20256.1%
Share count trendFY 2025 · to 28 Jan 2026-0.5%
Cash and equivalentsFY 2025 · to 31 Dec 2025$4.5B
Free cash flowFY 2025 · to 31 Dec 2025$1.5B

Analyst forecasts

No analyst forecasts yet.